
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
Ranjan K. Mohapatra, Nahed A. El‐Shall, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 24
Ranjan K. Mohapatra, Nahed A. El‐Shall, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 24
Showing 24 citing articles:
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia
Li Ping Wong, Haridah Alias, Yan-Li Siaw, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 37
Li Ping Wong, Haridah Alias, Yan-Li Siaw, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 37
Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies
Ranjit Sah, Mohammed Amir Rais, Aroop Mohanty, et al.
International Journal of Surgery Open (2023) Vol. 55, pp. 100625-100625
Open Access | Times Cited: 17
Ranjit Sah, Mohammed Amir Rais, Aroop Mohanty, et al.
International Journal of Surgery Open (2023) Vol. 55, pp. 100625-100625
Open Access | Times Cited: 17
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
Twitter-Based Sentiment Analysis and Topic Modeling of Social Media Posts Using Natural Language Processing, to Understand People’s Perspectives Regarding COVID-19 Booster Vaccine Shots in India: Crucial to Expanding Vaccination Coverage
Praveen SV, Jose Manuel Lorenz, Rajesh Ittamalla, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1929-1929
Open Access | Times Cited: 26
Praveen SV, Jose Manuel Lorenz, Rajesh Ittamalla, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1929-1929
Open Access | Times Cited: 26
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Angela Rose, Nathalie Nicolay, Virginia Martin, et al.
Eurosurveillance (2023) Vol. 28, Iss. 47
Open Access | Times Cited: 12
Angela Rose, Nathalie Nicolay, Virginia Martin, et al.
Eurosurveillance (2023) Vol. 28, Iss. 47
Open Access | Times Cited: 12
An update on SARS-CoV-2 immunization and future directions
Rashmi Rana, Ravi Kant, Tanya Kumra, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Rashmi Rana, Ravi Kant, Tanya Kumra, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis
George N. Okoli, Nicole Askin, Rasheda Rabbani
The Annals of Family Medicine (2024) Vol. 22, Iss. 4, pp. 336-346
Open Access | Times Cited: 3
George N. Okoli, Nicole Askin, Rasheda Rabbani
The Annals of Family Medicine (2024) Vol. 22, Iss. 4, pp. 336-346
Open Access | Times Cited: 3
SARS-CoV-2 emerging Omicron subvariants with a special focus on BF.7 and XBB.1.5 recently posing fears of rising cases amid ongoing COVID-19 pandemic
Kuldeep Dhama, Deepak Chandran, Hitesh Chopra, et al.
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 6, pp. 1215-1221
Open Access | Times Cited: 16
Kuldeep Dhama, Deepak Chandran, Hitesh Chopra, et al.
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 6, pp. 1215-1221
Open Access | Times Cited: 16
Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics
Sunita Panda, Puneet Kumar Singh, Snehasish Mishra, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 110-110
Open Access | Times Cited: 8
Sunita Panda, Puneet Kumar Singh, Snehasish Mishra, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 110-110
Open Access | Times Cited: 8
COVID-19 Booster Vaccination in Malaysia
Nor Elyzatul Akma Hamdan, Ali Omar Yassen, Mathumalar Loganathan Fahrni
Journal of Clinical and Health Sciences (2024) Vol. 9, Iss. 1, pp. 6-14
Open Access | Times Cited: 2
Nor Elyzatul Akma Hamdan, Ali Omar Yassen, Mathumalar Loganathan Fahrni
Journal of Clinical and Health Sciences (2024) Vol. 9, Iss. 1, pp. 6-14
Open Access | Times Cited: 2
Global domination of the recently VoI-classified 'JN.1′ outcompeting other variants – Comparing the vaccines’ efficacy
Ranjan K. Mohapatra, Venkataramana Kandi, Abhay Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 22, pp. 100358-100358
Open Access | Times Cited: 2
Ranjan K. Mohapatra, Venkataramana Kandi, Abhay Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 22, pp. 100358-100358
Open Access | Times Cited: 2
The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia
Li-Ann Hwang, Santha Vaithilingam, Jason Wei Jian Ng, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301383-e0301383
Open Access | Times Cited: 2
Li-Ann Hwang, Santha Vaithilingam, Jason Wei Jian Ng, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301383-e0301383
Open Access | Times Cited: 2
COVID‐19 vaccines and their underbelly: Are we going the right way?
Bhabani Sankar Satapathy, Gurudutta Pattnaik, Rudra Narayan Sahoo, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 7
Bhabani Sankar Satapathy, Gurudutta Pattnaik, Rudra Narayan Sahoo, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 7
The dual role of toll-like receptors in COVID-19: Balancing protective immunity and immunopathogenesis
Payam Behzadi, Deepak Chandran, Chiranjib Chakraborty, et al.
International Journal of Biological Macromolecules (2024), pp. 137836-137836
Closed Access | Times Cited: 1
Payam Behzadi, Deepak Chandran, Chiranjib Chakraborty, et al.
International Journal of Biological Macromolecules (2024), pp. 137836-137836
Closed Access | Times Cited: 1
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern
Erika Rudi, Pablo Martín Aispuro, Eugenia Zurita, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Erika Rudi, Pablo Martín Aispuro, Eugenia Zurita, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Risks of Adverse Outcomes for Hospitalized COVID-19 Patients during the Four Waves in Brazil According to SARS-CoV-2 Variants, Age Group, and Vaccine Status
Natália Satchiko Hojo-Souza, Waasila Jassat, Daniel L. Guidoni, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1997-1997
Open Access | Times Cited: 2
Natália Satchiko Hojo-Souza, Waasila Jassat, Daniel L. Guidoni, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1997-1997
Open Access | Times Cited: 2
Immunization against Medically Important Human Coronaviruses of Public Health Concern
Nabil Awni Nimer, Seema N Nimer
Canadian Journal of Infectious Diseases and Medical Microbiology (2024) Vol. 2024, Iss. 1
Open Access
Nabil Awni Nimer, Seema N Nimer
Canadian Journal of Infectious Diseases and Medical Microbiology (2024) Vol. 2024, Iss. 1
Open Access
Advanced biomaterials for regenerative medicine and their possible therapeutic significance in treating COVID-19: a critical overview
Ashish K. Sarangi, Mohamed A. Salem, Mustafa D. Younus, et al.
International Journal of Surgery (2024)
Open Access
Ashish K. Sarangi, Mohamed A. Salem, Mustafa D. Younus, et al.
International Journal of Surgery (2024)
Open Access
SARS-CoV-2 Omicron (B.1.1.529) variant: structural features, biological characteristics, impact on scientific research, general precautions and protective procedures; a systematic review
Prithivi Nagarajan, Anitha Vetrivel, J.B. Prasanna Kumar, et al.
Journal of Mind and Medical Sciences (2022) Vol. 9, Iss. 2, pp. 224-235
Open Access | Times Cited: 2
Prithivi Nagarajan, Anitha Vetrivel, J.B. Prasanna Kumar, et al.
Journal of Mind and Medical Sciences (2022) Vol. 9, Iss. 2, pp. 224-235
Open Access | Times Cited: 2
Monitoring algorithm of hospitalized patients in a medical center with SARS-CoV-2 (Omicron variant) infection: clinical epidemiological surveillance and immunological assessment
Chi-Sheng Chen, Ming‐Jr Jian, Chih-Kai Chang, et al.
PeerJ (2023) Vol. 11, pp. e14666-e14666
Open Access
Chi-Sheng Chen, Ming‐Jr Jian, Chih-Kai Chang, et al.
PeerJ (2023) Vol. 11, pp. e14666-e14666
Open Access
The Perspectives of Individuals with Comorbidities Towards COVID-19 Booster Vaccine Shots in Twitter: A Social Media Analysis Using Natural Language Processing, Sentiment Analysis and Topic Modeling
Praveen SV, R. Sundar, Vajratiya Vajrobol, et al.
Journal of Pure and Applied Microbiology (2023) Vol. 17, Iss. 1, pp. 567-575
Open Access
Praveen SV, R. Sundar, Vajratiya Vajrobol, et al.
Journal of Pure and Applied Microbiology (2023) Vol. 17, Iss. 1, pp. 567-575
Open Access
Application of AI in genome sequence analysis of Covid-19-A review
Bindhu Prabha, S. Divya, V. S Jijith
AIP conference proceedings (2023) Vol. 2921, pp. 020016-020016
Closed Access
Bindhu Prabha, S. Divya, V. S Jijith
AIP conference proceedings (2023) Vol. 2921, pp. 020016-020016
Closed Access
Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: Epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines
Ranjan K. Mohapatra, Véronique Seidel, Venkataramana Kandi, et al.
Frontiers research topics (2023)
Open Access
Ranjan K. Mohapatra, Véronique Seidel, Venkataramana Kandi, et al.
Frontiers research topics (2023)
Open Access